Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Daming Zhou(Centre for Human Genetics), Gavin Screaton(University of Oxford), Jose Slon-Campos(Centre for Human Genetics), Aekkachai Tuekprakhon(University of Birmingham), Guido C. Paesen(Centre for Human Genetics), William James(University of Oxford), Helen M. E. Duyvesteyn(Centre for Human Genetics), Naomi S. Coombes(Public Health England), Piyada Supasa(University of Oxford), Sue Charlton(Environment Agency), Eleanor Barnes(Oxford Health NHS Foundation Trust), Paul Klenerman(John Radcliffe Hospital), Elizabeth Clutterbuck(University of Oxford), Thomas S. Walter(Centre for Human Genetics), Helen M. Ginn(Instruct-ERIC), Rungtiwa Nutalai(Centre for Human Genetics), Christina Dold(University of Oxford), Donal Skelly(John Radcliffe Hospital), Alexander J. Mentzer(Centre for Human Genetics), César López‐Camacho(Centre for Human Genetics), Julian C. Knight(Chinese Academy of Medical Sciences & Peking Union Medical College), David I. Stuart(MRC Laboratory of Molecular Biology), Sarah C. Gilbert(Nuffield Orthopaedic Centre), Jingshan Ren(Centre for Human Genetics), Juthathip Mongkolsapaya(Centre for Human Genetics), Sheila Lumley(University of Oxford), Andrew J. Pollard(University of Oxford), Sagida Bibi(University of Oxford), Miles W. Carroll(Institute of Human Genetics), Wanwisa Dejnirattisai(Hammersmith Hospital), Yuguang Zhao(University of Oxford), Sandra Belij‐Rammerstorfer(University of Oxford), Tao Dong(Chinese Academy of Medical Sciences & Peking Union Medical College), Elizabeth E. Fry(University of Oxford), Bassam Hallis(Public Health England), Susanna Dunachie(Mahidol University), Amy Flaxman(University of Oxford), Kevin R. Bewley(UK Health Security Agency), Derrick W. Crook(John Radcliffe Hospital), Beibei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chang Liu(Paul Scherrer Institute), Teresa Lambe(Science Oxford), Robert H. Levin(Worthing Hospital), Mustapha Bittaye(University of Oxford)
Cited by 1,152
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Global distribution and prevalence of hepatitis C virus genotypes
|Hepatology|2014|1.6k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k